‡a
Author's Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s
‡a
raltegravirpharmacokineticsbeforeandduringtreatmentwithombitasvirparitaprevirritonavirplusdasabuvirinadultswithhumanimmunodeficiencyvirus1andhepatitis100viruscoinfectionaidsclinicaltrialsgroupsubstudya5334s
‡A
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s
‡9
1
‡a
intrahepaticviralkineticsduringdirectactingantiviralsforhepatitis100inhivcoinfectiontheactga5335ssubstudy
‡A
Intrahepatic Viral Kinetics during Direct-Acting Antivirals for Hepatitis C in HIV Co-infection:The ACTG A5335S Substudy
‡9
1